The new class of weight loss drugs like Ozempic, Wegovy and Mounjaro work to suppress appetite, which means users are reaching for sugary and salty foods less often. That change in eating behaviors is having an economic impact on snack companies, Wall Street and beyond. NBC’s Vicky Nguyen reports for TODAY.